Naive CD8 T cell functional heterogeneity
- Institution
- CINCINNATI CHILDRENS HOSP MED CTR, OH
- Principal investigator
- Koichi Araki
- Funding
- $639K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
Project Summary There has been considerable progress in identifying subsets in effector, memory, and exhausted CD8 T cells, and our understanding of the role of each subset in response to infection has greatly improved. However, much less is known about the heterogeneity of naïve CD8 T cells, the predecessors of these antigen-experienced T cells. We have recently tackled this important issue, and our preliminary data show that there is a naïve CD8 T cell population with a superior ability to generate more effector CD8 T cells after infection. A deeper understanding of the naïve CD8 T cell heterogeneity will help to develop strategies to produce just such a better naïve CD8 T cell population. Since naïve T cells have an enormous TCR repertoire diversity capable of recognizing virtually any non-self antigens including pathogens and tumor neoantigens, making a high-quality naïve T cell population that gives rise to potent effector and memory T cell responses would provide better protection against known and unknown pathogens, enhance responsiveness to existing vaccines, and even prevent the development of cancer. Our long-term objective is: To elucidate how naïve CD8 T cell heterogeneity is generated and maintained and to understand qualitative differences among naïve CD8 T cell subsets; Ultimately, to use this information to establish novel strategies to induce protective naïve CD8 T cell immunity against pathogens and cancer. Toward this objective, we will investigate both mouse and human naïve CD8 T cells. Our proposed studies in this application represent a new direction of research in the area of naïve CD8 T cell heterogeneity. The following specific aims are proposed: Specific Aim 1: To elucidate how naïve CD8 T cell heterogeneity contributes to immune response and homeostasis of T cells in mice. Specific Aim 2. To define human naïve CD8 T cell atlas by examining antigen specific CD8 T cells in the young and aged adults as well as newborns.
LOADING MOONBASE SCORE
Questions for CINCINNATI CHILDRENS HOSP MED CTR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Cincinnati Childrens Hosp Med Ctr54
Sirolimus TSC Epilepsy Prevention Study (STEPS) IND#145820 11/8/2019
Martina Bebin · $651K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr48
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
Michael Jordan · $530K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr44
Molecular signaling in uterine receptivity to implantation
Xiaofei Sun · $439K · 2011–2028